Atlas Trials

mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Clinical trial NCT05200299 · UNKNOWN

Trial details

NCT number
NCT05200299
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2022-02-01
Primary completion
2024-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.